Healthcare -
Biotechnology - NASDAQ - US
$ 8.67
9.61 %
$ 738 M
Market Cap
-15.76
P/E
AVXL - TOTAL EQUITY
Total Equity AVXL - Anavex Life Sciences Corp.
120 M
LAST VALUE
-8.13%
2 YEAR CAGR
42.75%
5 YEAR CAGR
90.35%
10 YEAR CAGR